"The Shadow on the Eye" is already available on the website: www.ei-lca.com
Enjoy! #clinicalTrial #blindness #LCA10
@perkinsvision.bsky.social svision.bsky.social
@therddr.bsky.social
@ei-lca.bsky.social
E&ILCA's main focus is global liaising for genetically caused blindness. E&ILCA initiates and fosters vast networks of top life-science clusters and most influential groups.
"The Shadow on the Eye" is already available on the website: www.ei-lca.com
Enjoy! #clinicalTrial #blindness #LCA10
@perkinsvision.bsky.social svision.bsky.social
@therddr.bsky.social
Leber Congenital Amaurosis Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis
04-25-2025
www.openpr.com/news/3987464...
September 16 & 17, 2025; Copenhagen, Denmark
nordicrarediseasesummit.org#ABODesire
Nordic Rare Disease Summit 2025
Act 2030: Pushing Boundaries for Rare
#RareDisease #lca10
The FDA has granted its Rare Pediatric Disease designation to Opus Geneticsβs OPGx-LCA5
www.ophthalmologymanagement.com/news/2024/op...
Register for the virtual experience. Stream convention general sessions, access the app, and get a chance to win door prizes.
July 8 through 13, 2025, plus pre-convention activities!
nfb.org/get-involved...
@fightblindness.bsky.social @riccobono.bsky.social #LCA10 #RareDisease #blindness
canadianrdn.ca/event/canair...
July 19th, Hybrid Workshop.
This workshop will co-design resources to support patients and families navigating the era of AI in medicine! The workshop is open to all and we welcome youth, adults, and families
@rnibradio.bsky.social #RareDisease #blindness
Wednesday, June 25th, 2025, 7:00 p.m. β 8:30 p.m. (PDT)
Presentation by Dr. Jacque Duncan from UCSF
www.fightingblindness.org/events/la-co...
@fightblindness.bsky.social @rnc.ac.uk #lca10 #RareDisease
@otdc-2026.bsky.social Oligonucleotide Therapeutics and Delivery Conference is all set to happen on March 23-24, 2026 as a hybrid event in Rome, Italy
oligo-nucleotide.com
#RareDisease #LCA10 #Blindness #oligonucleotide
Accelerate Ideas, Partnerships and Opportunities
Book your SLOT NOW
OTDC 2026
Oligonucleotide Therapeutics and Delivery Conference
March 23-24, 2026 | Rome, Italy
Website: oligo-nucleotide.com
globalgenes.org/rare-advocac...
Global Genesβ RARE Advocacy Exchange is a virtual event designed to empower, equip, and elevate individuals with the leadership skills to help make a change through a series of 8 sessions.
@globalgenes.bsky.social #blindness #LCA10 #RareDisease
#LCA10 #blindness #raredisease #orphandrugs
29.05.2025 07:17 β π 0 π 0 π¬ 0 π 0www.retinaaustralia.com.au
Retina Australia funds and facilitates the top medical research into inherited retinal diseases (IRDs) through a competitive annual Research Grants Program.
#LCA10 #RareDisease #OrphanDrugs
Artificial intelligence (AI) is a computer program built to perform a specific task. It gets better at that task the more it does it. This ability to learn can solve problems in medical research.
eye2gene.com
#raredisease #lca10 #retina
@ucldiscovery.bsky.social
Study to Evaluate Sepofarsen in Subjects with Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) (HYPERION)
clinical trial ID: NCT06891443
Sponsor- Laboratoires Thea. #blindness #LCA10 #CEP290
clinicaltrials.gov/study/NCT068...
Leber Congenital Amaurosis (LCA) is a rare inherited eye disorder that causes blindness in childhood.
ei-lca.com/hope-on-the-...
Groundbreaking gene therapy has restored vision in children born with leber congenital amaurosis (LCA), a severe genetic blindness.
www.bbc.co.uk/news/article...
1
Gene therapy shows genuine promise in a rare eye disease that causes blindness. The condition is known as Leber congenital amaurosis-1 & there have been "mind-boggling" effects, an ophthalmologist says, referring to eyesight returning to these patients www.medpagetoday.com/ophthalmolog...
14.09.2024 18:11 β π 19 π 7 π¬ 0 π 0Guardian: Doctors in London cure blindness in children with rare condition,
Leber congenital amaurosis
www.theguardian.com/society/2025...